Subscribe to TalkMarkets feed TalkMarkets
The latest posts from TalkMarkets
Updated: 2 hours 41 min ago

Money Market “Cash On The Sidelines” – A Myth That Won’t Die

Fri, 01/26/2024 - 04:28
The surge in money markets since the “pandemic” has revived the age-old narrative that “money on the sidelines” is set to come into the markets.

EURUSD And GBPUSD: EURUSD Slips To 1.08129 This Morning

Fri, 01/26/2024 - 04:24
This week, the EURUSD continued its bearish trend. Pair GBPUSD on Wednesday formed this week’s high at 1.27748 level.

US Market Commentary - Friday, Jan. 26

Fri, 01/26/2024 - 04:15
The US Dollar is pushing higher on Friday following yet a further set of positive data yesterday.

Daily Market Outlook - Friday, Jan. 26

Fri, 01/26/2024 - 04:00
Asian markets have experienced broad declines following a recent period of gains.

The ECB Left Rates Unchanged And Is Planning Its First Cut For The Summer

Fri, 01/26/2024 - 03:45
The European Central Bank, as expected, left its main refinancing rate unchanged at 4.50% and said that this level should be maintained for a long enough time to ensure that inflation returns to the 2% level in time.

GBP/JPY Lacks A Firm Intraday Direction, Manages To Hold Steady Above Mid-187.00s

Fri, 01/26/2024 - 03:32
The GBP/JPY cross remains on the defensive for the fourth successive day on Friday, albeit lacks follow-through selling and remains confined in the previous day's broader trading range through the first half of the European session.

All Eyes On Friday's US Core PCE

Fri, 01/26/2024 - 03:20
Thursday’s US Q4 GDP beat was offset by a larger-than-expected decline in the price index component and below forecast durable goods and jobless claims. In the end, the US Dollar comes into Friday relatively flat.

Elliott Wave Technical Analysis Day Chart: U.S. Dollar/Canadian Dollar - Friday, Jan. 26

Fri, 01/26/2024 - 02:55
Traders are advised to closely monitor the market, with a focus on the invalidation level at 1.35349.

Elliott Wave Technical Analysis 4 Hour Chart: U.S. Dollar/Canadian Dollar - Friday, Jan. 26

Fri, 01/26/2024 - 02:43
The USD/CAD Elliott Wave analysis indicates an impulsive counter-trend movement, with blue wave 5 of C in progress.

The Federal Government’s Version Of "Fiscal Responsibility" Offends Merriam And Webster

Fri, 01/26/2024 - 02:22
Politicians in Washington are so removed from reality that they truly believe their fiscal policies can do anything but hinder progress, hamper productivity, and forcibly distribute people’s property against their wishes.

Financial Planning Using Indices: From Taxes To Factors

Fri, 01/26/2024 - 01:37
A practical look at the importance of tax management and the role of indexing in building a comprehensive plan for clients.

Apple’s iPhone Leads China Tech Race With Tough Competition

Fri, 01/26/2024 - 00:08
In a surprising turn of events, Apple Inc.’s iPhone emerged as the best-selling smartphone series in China for the first time in 2023.

Russell 2000 Earnings Dashboard 23Q4

Thu, 01/25/2024 - 23:23
The 23Q4 Y/Y blended earnings growth estimate is -11.3%. If the energy sector is excluded, the growth rate for the index is -3.6%.

Bank Bailout Fund 'Arb' Usage Soars (Again) Amid Money-Market Fund Outflows, Large RRP Drain

Thu, 01/25/2024 - 22:38
Money-market fund assets fell for a second week in a row, led by the departure of assets from institutional funds, as investors continued to reallocate portfolios in the new year.

Is The U.S. Economy Actually Growing?

Thu, 01/25/2024 - 20:53
How is it possible that layoffs were up 98 percent in 2023 while the U.S. economy was supposedly “growing” all year long? It appears that something fishy is going on.

Rates Spark: Feeding The Doves

Thu, 01/25/2024 - 20:09
Euro curves bull steepened on the lack of pushback on rate cuts by ECB President Lagarde at the press conference.

Elliott Wave Analysis: S&P 500, Nasdaq 100, DAX 40, FTSE 100, ASX200

Thu, 01/25/2024 - 19:40
The current analysis of the market suggests that Elliott Wave iv) is on the verge of completing its course, revealing distinct patterns.

Chart Of The Day: Summit Therapeutics Begins To Soar

Thu, 01/25/2024 - 19:24
Summit Therapeutics Inc., a biopharmaceutical company, researches and develops primarily oncology therapies in the United States and the United Kingdom.

Let The Good Times Roll

Thu, 01/25/2024 - 18:39
Contrary to expectations at the start of last year, tighter monetary policy and credit conditions did not lead the U.S. economy into recession.

Dividend Aristocrat Growing Dividends For 67 Years Is Now On Sale

Thu, 01/25/2024 - 17:54
A detailed analysis of Genuine Parts with long-term dividend income and growth potential.

Pages